{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:22:03Z","timestamp":1766445723020,"version":"3.48.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jclinepi.2025.111890","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:11:42Z","timestamp":1750965102000},"page":"111890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical study report data did not substantially alter point estimates but improved precision in a nephrology systematic review"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-3936","authenticated-orcid":false,"given":"Julian","family":"Hirt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Breuing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-4527","authenticated-orcid":false,"given":"Mark R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-1144","authenticated-orcid":false,"given":"K\u00e4the","family":"Goossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2023","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","key":"10.1016\/j.jclinepi.2025.111890_bib1"},{"key":"10.1016\/j.jclinepi.2025.111890_bib2","first-page":"MR000035","article-title":"Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions","volume":"10","author":"Page","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jclinepi.2025.111890_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jrsm.1468","article-title":"Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: a review","volume":"12","author":"Page","year":"2020","journal-title":"Res Synth Meth"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111890_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176210","article-title":"Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research","volume":"12","author":"Schmucker","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.111890_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/sim.2025","article-title":"Identification and impact of outcome selection bias in meta-analysis","volume":"24","author":"Williamson","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2025.111890_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-11-37","article-title":"Reporting bias in medical research - a narrative review","volume":"11","author":"McGauran","year":"2010","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.jclinepi.2025.111890_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1503\/cmaj.1041086","article-title":"Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research","volume":"171","author":"Chan","year":"2004","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.jclinepi.2025.111890_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189309","article-title":"Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients","volume":"12","author":"Rohner","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111890_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002496","article-title":"Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports","volume":"3","author":"Doshi","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111890_bib12","first-page":"59","article-title":"Why clinical study reports really matter","volume":"27","author":"K\u00f6hler","year":"2018","journal-title":"Med Writing"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111890_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068981","article-title":"Clinical study reports published by the European Medicines Agency 2016-2018: a cross-sectional analysis","volume":"13","author":"Byrne","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111890_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-016-1327-z","article-title":"Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials","volume":"17","author":"Hodkinson","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2025.111890_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13643-018-0766-x","article-title":"The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors","volume":"7","author":"Hodkinson","year":"2018","journal-title":"Syst Rev"},{"key":"10.1016\/j.jclinepi.2025.111890_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmjebm-2018-110963","article-title":"When to include clinical study reports and regulatory documents in systematic reviews","volume":"23","author":"Jefferson","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jclinepi.2025.111890_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2490-2-6","article-title":"Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Urol"},{"key":"10.1016\/j.jclinepi.2025.111890_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12916-021-01955-0","article-title":"Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications-a methodological review","volume":"19","author":"Paludan-M\u00fcller","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jclinepi.2025.111890_bib19","article-title":"Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications","volume":"348","author":"Maund","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.111890_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001526","article-title":"Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data","volume":"10","author":"Wieseler","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jclinepi.2025.111890_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4737","article-title":"Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials","volume":"341","author":"Eyding","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111890_bib22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.ajkd.2019.10.004","article-title":"Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Goossen","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jclinepi.2025.111890_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13643-019-0959-y","article-title":"The role of icodextrin in peritoneal dialysis: protocol for a systematic review and meta-analysis","volume":"8","author":"Becker","year":"2019","journal-title":"Syst Rev"},{"issue":"Suppl 5","key":"10.1016\/j.jclinepi.2025.111890_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ndt\/16.suppl_5.61","article-title":"Integrated end-stage renal disease care: the role of peritoneal dialysis","volume":"16","author":"Blake","year":"2001","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jclinepi.2025.111890_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"author":"Hirt","key":"10.1016\/j.jclinepi.2025.111890_bib26"},{"key":"10.1016\/j.jclinepi.2025.111890_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.12.019","article-title":"No inexplicable disagreements between real-world data-based nonrandomized controlled studies and randomized controlled trials were found","volume":"133","author":"Mathes","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111890_bib29","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","first-page":"421","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2023"},{"issue":"9","key":"10.1016\/j.jclinepi.2025.111890_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3346\/jkms.2014.29.9.1217","article-title":"Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients","volume":"29","author":"Yoon","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111890_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/089686080102100308","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism","volume":"21","author":"Bredie","year":"2001","journal-title":"Perit Dial Int"},{"issue":"13","key":"10.1016\/j.jclinepi.2025.111890_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002991","article-title":"Effect of icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jclinepi.2025.111890_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12882-018-0912-7","article-title":"Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: comparison between icodextrin solution and glucose-based solution","volume":"19","author":"Chen","year":"2018","journal-title":"BMC Nephrol"},{"issue":"S2","key":"10.1016\/j.jclinepi.2025.111890_bib34","first-page":"S71","article-title":"Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis","volume":"19","author":"Chow","year":"2014","journal-title":"Nephrology"},{"issue":"7","key":"10.1016\/j.jclinepi.2025.111890_bib35","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/gfu033","article-title":"Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis","volume":"29","author":"Chow","year":"2014","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111890_bib36","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings","year":"2003","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111890_bib37","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","article-title":"Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)","volume":"30","author":"de Moraes","year":"2015","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111890_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111890_bib39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"year":"1998","series-title":"A study to evaluate the safety and efficacy of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis (APD): Clinical Study Report PRO-RENAL-REG-035","key":"10.1016\/j.jclinepi.2025.111890_bib40"},{"year":"2000","series-title":"7.5% Icodextrin Peritoneal Dialysis Solution- A Study to Evaluate the Safety and Efficacy of a 7.5% Icodextrin Peritoneal Dialysis Solution in Patients Treated with Continuous Ambulatory Peritoneal Dialysis (CAPD): Clinical Study Report RD-97-CA-130","key":"10.1016\/j.jclinepi.2025.111890_bib41"},{"year":"2000","series-title":"A Study to Evaluate the Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Patients Treated with Peritoneal Dialysis (PD) in North America: Clinical Study Report RD-97-CA-131","key":"10.1016\/j.jclinepi.2025.111890_bib42"},{"year":"2000","series-title":"Assessment of the biocompatibility of glucose polymer solution in automated peritoneal dialysis (APD): Clin Study Rep ML\/IB 011 (Diana)","key":"10.1016\/j.jclinepi.2025.111890_bib43"},{"year":"2000","series-title":"Multicentre Clinical Trial oflcodextrin in CAPD Final Report Addendum (MIDAS): Clinical Study Report ML\/IB 001","key":"10.1016\/j.jclinepi.2025.111890_bib44"},{"year":"2001","series-title":"A Clinical Comparison Study of BLPG in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD): Clinical Study Report BLR-PG22","key":"10.1016\/j.jclinepi.2025.111890_bib45"},{"year":"2002","key":"10.1016\/j.jclinepi.2025.111890_bib46"},{"year":"2004","key":"10.1016\/j.jclinepi.2025.111890_bib47"},{"year":"2006","key":"10.1016\/j.jclinepi.2025.111890_bib48"},{"issue":"9","key":"10.1016\/j.jclinepi.2025.111890_bib49","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111890_bib50","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2004090793","article-title":"Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration","volume":"16","author":"Finkelstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111890_bib51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089686089501500309","article-title":"Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS study group. Multicenter investigation of icodextrin in ambulatory dialysis","volume":"15","author":"Gokal","year":"1995","journal-title":"Perit Dial Int"},{"issue":"S81","key":"10.1016\/j.jclinepi.2025.111890_bib52","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1046\/j.1523-1755.62.s81.10.x","article-title":"Early quality of life benefits of icodextrin in peritoneal dialysis","author":"Guo","year":"2002","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111890_bib53","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.02950509","article-title":"Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid","volume":"4","author":"Lin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111890_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ki.1994.300","article-title":"A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis","volume":"46","author":"Mistry","year":"1994","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111890_bib55","first-page":"211","article-title":"Clinical results of icodextrin dialysis solution in Japan: results of a double-blind comparative study using glucose dialysate as a control drug","volume":"55","author":"Ota","year":"2003","journal-title":"Kidney Dial"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111890_bib56","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"S2","key":"10.1016\/j.jclinepi.2025.111890_bib57","first-page":"S106","article-title":"Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis","volume":"20","author":"Posthuma","year":"2000","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111890_bib58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/12.3.550","article-title":"Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111890_bib59","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/ajkd.2002.36344","article-title":"A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis","volume":"40","author":"Wolfson","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111890_bib60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/089686089701700613","article-title":"Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell","volume":"17","author":"Posthuma","year":"1997","journal-title":"Perit Dial Int"},{"year":"2002","key":"10.1016\/j.jclinepi.2025.111890_bib61"},{"year":"2002","author":"Yu","key":"10.1016\/j.jclinepi.2025.111890_bib62"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111890_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13643-019-0983-y","article-title":"Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports","volume":"9","author":"J\u00f8rgensen","year":"2020","journal-title":"Syst Rev"},{"key":"10.1016\/j.jclinepi.2025.111890_bib64","doi-asserted-by":"crossref","first-page":"111263","DOI":"10.1016\/j.jclinepi.2024.111263","article-title":"Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation","volume":"167","author":"Hopkins","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111890_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jclinepi.2022.02.004","article-title":"Substantial delays in clinical data published by the European Medicines Agency - a cross sectional study","volume":"146","author":"Paludan-M\u00fcller","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2025.111890_bib67","article-title":"How to use FDA drug approval documents for evidence syntheses","volume":"362","author":"Ladanie","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111890_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/21614083.2021.1989172","article-title":"Centralised full access to clinical study data can support unbiased guideline development, continuing medical education, and patient information","volume":"10","author":"McGauran","year":"2021","journal-title":"J Eur CME"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111890_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/17407745211038524","article-title":"Characteristics of available studies and dissemination of research using major clinical data sharing platforms","volume":"18","author":"Vazquez","year":"2021","journal-title":"Clin Trials"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625002239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625002239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:18:21Z","timestamp":1766445501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625002239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"alternative-id":["S0895435625002239"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111890","relation":{},"ISSN":["0895-4356"],"issn-type":[{"type":"print","value":"0895-4356"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical study report data did not substantially alter point estimates but improved precision in a nephrology systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111890"}}